Evidenzbasierte Leitlinie zur Psychotherapie der Sozialen Angststörung Bd. 03 (German Edition)

Free download. Book file PDF easily for everyone and every device. You can download and read online Evidenzbasierte Leitlinie zur Psychotherapie der Sozialen Angststörung Bd. 03 (German Edition) file PDF Book only if you are registered here. And also you can download or read online all Book PDF file that related with Evidenzbasierte Leitlinie zur Psychotherapie der Sozialen Angststörung Bd. 03 (German Edition) book. Happy reading Evidenzbasierte Leitlinie zur Psychotherapie der Sozialen Angststörung Bd. 03 (German Edition) Bookeveryone. Download file Free Book PDF Evidenzbasierte Leitlinie zur Psychotherapie der Sozialen Angststörung Bd. 03 (German Edition) at Complete PDF Library. This Book have some digital formats such us :paperbook, ebook, kindle, epub, fb2 and another formats. Here is The CompletePDF Book Library. It's free to register here to get Book file PDF Evidenzbasierte Leitlinie zur Psychotherapie der Sozialen Angststörung Bd. 03 (German Edition) Pocket Guide.

Advertisement Hide. Living reference work entry First Online: 17 November This is a preview of subscription content, log in to check access. Abass A, Driessen E The efficacy of short-term psychodynamic psychotherapy for depression — a summary of recent findings. Abraham K Psychoanalytische Studien. Fischer, Frankfurt Google Scholar. Schattauer, Stuttgart Google Scholar.

Adli M, Baethge C, Heinz A et al Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review. Adli M, Pilhatsch M, Bauer M et al Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.

Akiskal HS Dysthymia: clinical and external validity. Alexopoulos GS Depression in the elderly.

Angst- und Panikstörungen im Überblick für Heilpraktiker Psychotherapie

Alnaes R, Torgersen S Personality and personality disorders among patients with various affective disorders. American Psychiatric Association Practice guideline for the treatment of patients with major depressive disorder, 3. Anderson I Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. Anderson F, Schade R, Suissa S et al Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus.

Zusammenfassung

Andrade C, Sandarsh S, Chethan K et al Serotonin reuptake inhibitors antidepressants and abnormal bleeding: a review for clinicians and reconsideration of mechanisms. Anglin R, Yuan Y, Moayyedi P et al Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis.

Angst J Verlauf unipolarer depressiver, bipolar manisch-depressiver und schizo-affektiver Erkrankungen und Psychosen. Ergebnisse einer prospektiven Studie. Angst J The history and concept of recurrent brief depression. Angst J, Hengartner MP, Alex G et al Mortality of patients with mood disorders 48 to 52 years after their psychiatric hospitalisation. Anisman H Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. Ansseau M, Von Frenkell R, Cerfontaine J et al Blunted response of growth hormone to clonidine and apomorphine in endogenous depression.

The Oreon Study. Armitage R Sleep and circadian rhythms in mood disorders. Arnone D, Mumuni AN, Jauhar S et al Indirect evidence of selective glial involvement in glutamate-based mechanisms of mood regulation in depression: meta-analysis of absolute prefrontal neuro-metabolic concentrations. Am J Psychiatry. A meta-analysis. Arzneiverordnung in der Praxis 33 Sonderheft 1. S 1— Baethge C, Gruschka P, Smolka M et al Effectiveness and outcome predictors of long-term lithium prophylaxis in unipolar major depressive disorder. Bagby RM, Quilty LC, Segal ZV et al Personality and differential treatment response in major depression: a randomized controlled trial comparing cognitive-behavioural therapy and pharmacotherapy.

Int J Neuropsychopharmacol — Google Scholar. Baghai TC, Blier P, Baldwin DS et al Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders.

Baldwin DS Recurrent brief depression. Baldwin RC Is vascular depression a distinct sub-type of depressive disorder? A review of causal evidence.

Baldwin RC, Gallagley A, Gourlay M et al Prognosis of late life depression: a three-year cohort study of outcome and potential predictors. Ballard ED et al Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety. Barbee J, Conrad E, Jamhour N The effectiveness of olanzapine, risperidone, quetiapine, and ziprasidone as augmentation agents in treatment-resistant major depressive disorder.

Barbui C, Hotopf M Amitriptyline v. Barbui C, Percudani M, Hotopf M Economic evaluation of antidepressive agents: a systematic critique of experimental and observational studies. Systematic review and meta-regression analysis. Barbui C, Esposito E, Cipriani A Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies.

Bares M, Novak T, Kopecek M et al Antidepressant monotherapy and combination of antidepressants in the treatment of resistant depression in current clinical practice: a retrospective study. Barton YA, Miller L, Wickramaratne P et al Religious attendance and social adjustment as protective against depression: a year prospective study.

Pharmacopsychiatry — CrossRef Google Scholar. Bauer M Neurobiologie und Therapie depressiver Erkrankungen, 5. Uni-Med, Bremen Google Scholar.

Bauer M, Dopfmer S Lithium augmentation in treatment-resistant depression. Meta-analysis of placebo-controlled studies. Bauer M, Tharmanathan P, Volz HP et al The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression. Bauer M, El-Khalili N, Datto C et al A pooled analysis of two randomized placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder. Bauer M, Whybrow P, Angst J et al b World Federation of Societies of Biological Psychiatry WFSBP Guidelines for biological treatment of unipolar depressive disorders, part 2: maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subtreshold depressions.

Baumann P Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.

Thieme E-Journals - Diabetologie und Stoffwechsel / Full Text

Baumeister H, Hutter N, Bengel J Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression. Baynes D, Mulholland C, Cooper SJ et al Depressive symptoms in stable chronic schizophrenia: prevalence and relationship to psychopathology and treatment. Bech P Social functioning: should it become an endpoint in trials of antidepressants? Beesdo K et al Incidence and risk patterns of anxiety and depressive disorders and categorization of generalized anxiety disorder.

Benazzi F How could antidepressants worsen unipolar depression? Benedetti G Analytische Psychotherapie der affektiven Psychosen. Bd 5 Affektive Psychosen. Stellenwert psychotherapeutischer Verfahren. A systematic review of current randomized trials. Guilford, New York Google Scholar. Depress Anxiety —6. Psychoneuroendocrinol — CrossRef Google Scholar. Blacker D Maintenance treatment of major depression: a review of the literature. Blier P Neurotransmitter targeting in the treatment of depression.

Blier P Ration site-directed pharmacotherapy for major depressive disorder. Blier P, Gobbi G, Turcotte JE et al Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation. J Affect Disord —47 Google Scholar.

To continue, please check the box below:

Bockting C, Spinhoven P, Koeter M et al Prediction of recurrence in recurrent depression and the influence of consecutive episodes on vulnerability for depression: a 2-year prospective study. Kohlhammer, Stuttgart, S — Google Scholar.

Stéphane Grappelli ? A Life In The Jazz Century - Stéphane Grappelli

Repertory-grid technique. Bond M Psychodynamic psychotherapy in the treatment of mood disorders. Bonnet U Moclobemide: therapeutic use and clinical studies. Nervenheilk — Google Scholar. Bracht T, Linden D, Keedwell P A review of white matter microstructure alterations of pathways of the reward circuit in depression. Behandlung chronischer Depressionen. Beltz, Weinheim Google Scholar.


  1. Stephane Grappelli: A Life in Jazz.
  2. Alexander L | Book Depository.
  3. Secrets of Successful Writers!
  4. Stéphane Grappelli - Wikipedia!

Bratek A, Zawade K, Beil-Gawelczyk J et al Depressiveness, symptoms of anxiety and cognitive dysfunctions in patients with asthma and chronic obstructive pulmonary disease COPD : possible associations with inflammation markers: a pilot study. Reasons and remedies. Bridle C, Spanjers K, Patel S et al Effect of exercise on depression severity in older people: systematic review and meta-analysis of randomized controlled trials.

Brown GW A psychosocial perspective and the aetiology of depression.